Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of TNFRSF10B monoclonal antibody, clone DR5-01-1
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Mouse |
| Applications | Flow Cyt |
More info about TNFRSF10B monoclonal antibody, clone DR5-01-1
| Brand: | Abnova |
| Reference: | MAB3876 |
| Product name: | TNFRSF10B monoclonal antibody, clone DR5-01-1 |
| Product description: | Mouse monoclonal antibody raised against partial recombinant TNFRSF10B. |
| Clone: | DR5-01-1 |
| Isotype: | IgG1 |
| Gene id: | 8795 |
| Gene name: | TNFRSF10B |
| Gene alias: | CD262|DR5|KILLER|KILLER/DR5|TRAIL-R2|TRAILR2|TRICK2|TRICK2A|TRICK2B|TRICKB|ZTNFR9 |
| Gene description: | tumor necrosis factor receptor superfamily, member 10b |
| Immunogen: | Recombinant Fc fusion protein corresponding to extracellular region of human TNFRSF10B. |
| Form: | Liquid |
| Recommend dilutions: | Flow Cytometry (1-10 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS, pH 7.4 (0.09% sodium azide) |
| Storage instruction: | Store at 4°C. Do not freeze. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Mouse |
| Antigen species / target species: | Human |
| Specificity: | This antibody recognizes an extracellular domain of TRAIL-R2 (DR5). TRAIL-R2is one of two TNF superfamily member intracellular death domain containing receptors for TRAIL (APO2L). |
| Reactivity: | Human |
| Applications: | Flow Cyt |
| Shipping condition: | Blue Ice |
| Publications: | TRAIL, caspases and maturation of normal and leukemic myeloid precursors.Corallini F, Milani D, Nicolin V, Secchiero P. Leuk Lymphoma. 2006 Aug;47(8):1459-68. |